Skip to main content

Leonteq Securities AG

Broker-Dealer

Position in VKTX — Viking Therapeutics, Inc.

CIK 1535950 ZURICH, V8

Position in VKTX

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$742,302
+$254,673 QoQ
Shares Held
22,812
+64.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Sep 30, 2025
CallValue
$105,120
CallShares
4,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Leonteq Securities AG holds $25,859,639 across 58 Biotechnology names. VKTX ranks #5 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VKTX
Viking Therapeutics, Inc.
This page
22,812 $742,302

All Filings in VKTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $742,302 22,812
2025-12-31 $487,629 13,861
2025-09-30 $371,993 14,155
2025-09-30 $105,120 4,000
2025-06-30 $254,559 9,606
2025-03-31 $377,875 15,647
2024-12-31 $457,448 11,368
2024-09-30 $510,215 8,059
2024-06-30 $233,456 4,404
2024-03-31 $250,756 3,058
2023-12-31 $1,861 100